Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-19

Clinical Trial Update: SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating everolimus-based strategies for steroid or cyclosporine withdrawal after kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afinitor (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplanted Recipients | Phase 4 | Status: COMPLETED | Results posted: 2013-08-19